About NorrDia

NorrDia is headquartered in Lund, Sweden, the center of the Medical and Biotech Innovation in the Nordics. It was founded 2021 by a group of business executives with a successful track record and experience from acute and chronic renal care in Gambro and Baxter.

The NorrDia team consists of people with decades of experience from Gambro and a wide international network. This enables us to focus both on acute and chronic care settings. Our legacy and clinical experience in combination with a strong focus on simplicity and reliability, provide professionals with the right tools to improve quality of care.

NorrDia provides chronic and acute care products for renal patients enabling healthcare professionals to improve quality of care.

TianYi Medical is the main shareholder of NorrDia and has a complete footprint for development and manufacturing of medical devices. TianYi was founded in 1998, the main shareholders are the father and the son, Zhimin Wu and Sam Wu.

The relationship between the two companies creates an exciting opportunity for NorrDia to realise its vision.

Read more about the NorrDia story and our latest news.